Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1–2 Central Lymph Node Metastases

BackgroundPapillary thyroid cancer (PTC) in clinically lymph node-negative (cN0) patients is prone toward lymph node metastasis. As a risk factor for tumor persistence and local recurrence, lateral lymph node metastasis (LLNM) is related to the number of central lymph node metastases (CLNMs).Methods...

Full description

Bibliographic Details
Main Authors: Yuanyuan Wang, Chang Deng, Xiujie Shu, Ping Yu, Huaqiang Wang, Xinliang Su, Jinxiang Tan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.716728/full
_version_ 1819009060789288960
author Yuanyuan Wang
Chang Deng
Xiujie Shu
Ping Yu
Huaqiang Wang
Xinliang Su
Jinxiang Tan
author_facet Yuanyuan Wang
Chang Deng
Xiujie Shu
Ping Yu
Huaqiang Wang
Xinliang Su
Jinxiang Tan
author_sort Yuanyuan Wang
collection DOAJ
description BackgroundPapillary thyroid cancer (PTC) in clinically lymph node-negative (cN0) patients is prone toward lymph node metastasis. As a risk factor for tumor persistence and local recurrence, lateral lymph node metastasis (LLNM) is related to the number of central lymph node metastases (CLNMs).MethodsWe performed LLNM risk stratification based on the number of CLNMs for cN0 PTC patients who underwent thyroidectomy and lymph node dissection between January 2013 and December 2018. A retrospective analysis was applied to the 274 collected patients with 1-2 CLNMs. We examined the clinicopathological characteristics of the patients and constructed a LASSO model.ResultsIn the 1–2 CLNM group, tumors >10 mm located in the upper region and nodular goiters were independent risk factors for LLNM. Specifically, tumors >20 mm and located in the upper region contributed to metastasis risk at level II. Hashimoto’s thyroiditis reduced this risk (p = 0.045, OR = 0.280). Age ≤ 30 years and calcification (microcalcification within thyroid nodules) correlated with LLNM. The LASSO model divided the population into low- (25.74%) and high-risk (57.25%) groups for LLNM, with an AUC of 0.715.ConclusionsFor patients with 1–2 CLNMs, young age, calcification, nodular goiter, tumor >10 mm, and tumor in the upper region should alert clinicians to considering a higher occult LLNM burden. Close follow-up and therapy adjustment may be warranted for high-risk patients.
first_indexed 2024-12-21T00:50:22Z
format Article
id doaj.art-cdb041c2b79e4db7a4f8a248efd1ce98
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-21T00:50:22Z
publishDate 2021-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-cdb041c2b79e4db7a4f8a248efd1ce982022-12-21T19:21:25ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-10-011210.3389/fendo.2021.716728716728Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1–2 Central Lymph Node MetastasesYuanyuan Wang0Chang Deng1Xiujie Shu2Ping Yu3Huaqiang Wang4Xinliang Su5Jinxiang Tan6Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Hepatobiliary, Breast and Thyroid Surgery, The People’s Hospital of Nanchuan, Chongqing, ChinaDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaBackgroundPapillary thyroid cancer (PTC) in clinically lymph node-negative (cN0) patients is prone toward lymph node metastasis. As a risk factor for tumor persistence and local recurrence, lateral lymph node metastasis (LLNM) is related to the number of central lymph node metastases (CLNMs).MethodsWe performed LLNM risk stratification based on the number of CLNMs for cN0 PTC patients who underwent thyroidectomy and lymph node dissection between January 2013 and December 2018. A retrospective analysis was applied to the 274 collected patients with 1-2 CLNMs. We examined the clinicopathological characteristics of the patients and constructed a LASSO model.ResultsIn the 1–2 CLNM group, tumors >10 mm located in the upper region and nodular goiters were independent risk factors for LLNM. Specifically, tumors >20 mm and located in the upper region contributed to metastasis risk at level II. Hashimoto’s thyroiditis reduced this risk (p = 0.045, OR = 0.280). Age ≤ 30 years and calcification (microcalcification within thyroid nodules) correlated with LLNM. The LASSO model divided the population into low- (25.74%) and high-risk (57.25%) groups for LLNM, with an AUC of 0.715.ConclusionsFor patients with 1–2 CLNMs, young age, calcification, nodular goiter, tumor >10 mm, and tumor in the upper region should alert clinicians to considering a higher occult LLNM burden. Close follow-up and therapy adjustment may be warranted for high-risk patients.https://www.frontiersin.org/articles/10.3389/fendo.2021.716728/fullcN0PTCLLNMCLNMLASSO
spellingShingle Yuanyuan Wang
Chang Deng
Xiujie Shu
Ping Yu
Huaqiang Wang
Xinliang Su
Jinxiang Tan
Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1–2 Central Lymph Node Metastases
Frontiers in Endocrinology
cN0
PTC
LLNM
CLNM
LASSO
title Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1–2 Central Lymph Node Metastases
title_full Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1–2 Central Lymph Node Metastases
title_fullStr Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1–2 Central Lymph Node Metastases
title_full_unstemmed Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1–2 Central Lymph Node Metastases
title_short Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1–2 Central Lymph Node Metastases
title_sort risk factors and a prediction model of lateral lymph node metastasis in cn0 papillary thyroid carcinoma patients with 1 2 central lymph node metastases
topic cN0
PTC
LLNM
CLNM
LASSO
url https://www.frontiersin.org/articles/10.3389/fendo.2021.716728/full
work_keys_str_mv AT yuanyuanwang riskfactorsandapredictionmodeloflaterallymphnodemetastasisincn0papillarythyroidcarcinomapatientswith12centrallymphnodemetastases
AT changdeng riskfactorsandapredictionmodeloflaterallymphnodemetastasisincn0papillarythyroidcarcinomapatientswith12centrallymphnodemetastases
AT xiujieshu riskfactorsandapredictionmodeloflaterallymphnodemetastasisincn0papillarythyroidcarcinomapatientswith12centrallymphnodemetastases
AT pingyu riskfactorsandapredictionmodeloflaterallymphnodemetastasisincn0papillarythyroidcarcinomapatientswith12centrallymphnodemetastases
AT huaqiangwang riskfactorsandapredictionmodeloflaterallymphnodemetastasisincn0papillarythyroidcarcinomapatientswith12centrallymphnodemetastases
AT xinliangsu riskfactorsandapredictionmodeloflaterallymphnodemetastasisincn0papillarythyroidcarcinomapatientswith12centrallymphnodemetastases
AT jinxiangtan riskfactorsandapredictionmodeloflaterallymphnodemetastasisincn0papillarythyroidcarcinomapatientswith12centrallymphnodemetastases